- Increased clearance explains lower plasma levels of tissue-type plasminogen activator by estradiol: Evidence for potently enhanced mannose receptor expression in mice
- Markers of fibrinolytic potency and clotting activation in stable angina pectoris: Role of urokinase, assessment of atrioventricular differences and correlation with coronary patency
- Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study
- Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator
- The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: Effect of thrombomodulin
- Evaluation of a bioimmuno assay for t-PA activity and its relation to PAI-1 activity and antigen levels
- Hypocoagulant and lipid-lowering effects of dietary n-3 polyunsaturated fatty acids with unchanged platelet activation in rats
- Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM
- Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris